Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|December 20, 2013
Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growthAntony Prabhu, Bhaswati Sarcar, Soumen Kahali, et al.
Cancer Research|October 3, 2012
The metabolomic signature of malignant glioma reflects accelerated anabolic metabolismPrakash Chinnaiyan, Elizabeth Kensicki, Gregory Bloom, et al.
ACS Sensors|April 27, 2026
Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal AdenocarcinomaKarishma Kailass, Alexandra F Tassielli, Ruifan Dai, et al.
Plos One|June 17, 2021
CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell linesGabriela M Wright, Nick T Gimbrone, Bhaswati Sarcar, et al.
Neuro-Oncology|October 27, 2011
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastomaPrakash Chinnaiyan, Sajeel Chowdhary, Lisa Potthast, et al.
Molecular & Cellular Proteomics : MCP|November 4, 2022
A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular VesiclesBhaswati Sarcar, Bin Fang, Victoria Izumi, et al.
FEBS Open Bio|July 18, 2019
Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 modelBhaswati Sarcar, Nicholas T Gimbrone, Gabriela Wright, et al.
Molecular Carcinogenesis|April 12, 2023
Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancerDiego Alem, Xinrui Yang, Francisca Beato, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 10, 2020
Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreasFrancisca Beato, Dayana Reverón, Kaleena B Dezsi, et al.
Cancer Research|October 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung CancerHitendra S Solanki, Harshit Shah, Denis Imbody, et al.
Pageof 3